Evidence map›Paper›PMID 42871379›Full record

ArticleAME case reports2026

Prolonged survival in a 57-year-old female with

Liping Kang, Liping Zhao, Xiaolong Chen, Ning Kang, Peiyun Long, Cong Kang, Jianhong Li, Guoping Zhang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liping KangDepartment of Medical Oncology, Yuebei People's Hospital, Shaoguan, China.
Liping ZhaoDepartment of Medical Oncology, Yuebei People's Hospital, Shaoguan, China.
Xiaolong ChenDepartment of Medical Oncology, Yuebei People's Hospital, Shaoguan, China.
Ning KangDepartment of Medical Oncology, Yuebei People's Hospital, Shaoguan, China.
Peiyun LongDepartment of Medical Oncology, Yuebei People's Hospital, Shaoguan, China.
Cong KangDepartment of Medical Oncology, Yuebei People's Hospital, Shaoguan, China.
Jianhong LiDepartment of Medical Oncology, Yuebei People's Hospital, Shaoguan, China.
Guoping ZhangDepartment of Medical Oncology, Yuebei People's Hospital, Shaoguan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The transformed small-cell lung cancer (T-SCLC) has a dismal prognosis, yet there remains a lack of standardized therapeutic guidelines. While this transformation is predominantly driven by concurrent loss of Case Description: A 57-year-old non-smoking woman with no significant prior medical history presented with persistent dizziness, headaches, and vomiting. She was diagnosed with Conclusions: This case highlights a rare

Indexed as

case reportEGFR-mutantlung adenocarcinoma (LADC)transformed small-cell lung cancer (T-SCLC)

Identifiers

PMID42871379
PMCPMC13659117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.